|
Volumn , Issue , 1996, Pages
|
Boom in Ritalin sales raises ethical issues.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
METHYLPHENIDATE;
PSYCHOTROPIC AGENT;
ADULT;
ARTICLE;
ATTENTION DEFICIT DISORDER;
BEHAVIOR;
BEHAVIOR CONTROL;
CHILD;
HEALTH;
HUMAN;
MENTAL DISEASE;
MENTAL HEALTH THERAPIES;
PATIENT CARE;
PHYSICIAN;
POPULAR APPROACH/SOURCE;
PROFESSIONAL PATIENT RELATIONSHIP;
PSYCHIATRY;
UNITED STATES;
MENTAL HEALTH THERAPIES;
POPULAR APPROACH/SOURCE;
PROFESSIONAL PATIENT RELATIONSHIP;
ADULT;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
BEHAVIOR;
BEHAVIOR CONTROL;
CHILD;
HEALTH;
HUMANS;
MENTAL DISORDERS;
METHYLPHENIDATE;
PATIENT CARE;
PHYSICIANS;
PSYCHIATRY;
PSYCHOTROPIC DRUGS;
UNITED STATES;
|
EID: 0030585285
PISSN: 03624331
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (12)
|
References (0)
|